<DOC>
	<DOCNO>NCT00003599</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development recurrence cancer . The use isotretinoin may effective way prevent lung cancer . Vitamin E may prevent side effect isotretinoin therapy . PURPOSE : Randomized clinical trial study effectiveness vitamin E prevent side effect isotretinoin former current smoker receive isotretinoin prevent lung cancer .</brief_summary>
	<brief_title>Vitamin E Preventing Side Effects Isotretinoin Former Current Smokers Who Are Receiving Isotretinoin Prevent Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether addition alpha-tocopherol ( AT ; vitamin E ) isotretinoin decrease incidence Grade II high toxicity isotretinoin administer former current smoker . II . Determine compliance rate isotretinoin smoker former smoker without AT six month period . III . Determine feasibility recruit former current smoker without AT six month period . IV . Determine effect isotretinoin administration serum retinol retinol-binding protein level patient . OUTLINE : This randomize , placebo control study . Patients stratify smoke status ( current smoker v former smoker ) age ( le 50 v 50 ) . Patients randomized take alpha-tocopherol ( AT ) orally isotretinoin orally daily ( arm I ) isotretinoin orally plus AT placebo orally daily ( arm II ) . Treatment arm continue 6 month . Patients follow 1 , 3 , 6 , 7 month start treatment . PROJECTED ACCRUAL : There 300 patient ( 150 per arm ) accrue study estimate 9 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Current smoker 20+ pack per year history smoking OR Former smoker discontinue smoke 1 year prior registration ( le 5 cigarette prior year ) 20+ pack per year history prior discontinue smoke PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : WBC great 3,000/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL SGOT le 40 IU/mL OR SGPT less IU/mL Renal : Not specify Other : Fasting triglyceride le 320 mg/dL No prior malignancy past 5 year except nonmelanoma skin cancer noninvasive cervical cancer No history malabsorption syndrome Not pregnant Effective contraception require fertile person PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior isotretinoin Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : No prior warfarin derivative At least 3 month since megadose vitamin A ( great 25,000 IU/day ) betacarotene great 30 mg/day alphatocopherol least 400 IU daily No concurrent megadose vitamin A ( great 25,000 IU/day ) , betacarotene great 30 mg/day , alphatocopherol least 400 IU daily , daily supplement tonic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
</DOC>